DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Cherney DZI, Zinman B, Inzucchi SE. et al.
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
Lancet Diabetes Endocrinol 2017;
5: 610-621
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.